Translational Research for Patients Post-MI - What Works and What Does Not Work? - Timothy Henry

↳ This is a section part of Moment: CRT 2017: ACS & AMI Management - STEMI 2017 Contemporary Topics

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$14.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Translational Research for Patients Post-MI - What Works and What Does Not Work? - Timothy Henry  at CRT 2017.

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$14.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Cardiologists
  • Interventional Cardiologists
  • Interventional Fellows
  • Interventional Radiologists
  • Vascular Surgeons
  • Emergency Physicians
  • Physicians with an interest in Cardiovascular Innovations

Learning Objectives

Other Components in this Moment

Overview
Benefits and Risks of Manual Thrombectomy in STEMI - Davide Capodanno
Microvascular Obstruction and No-Reflow - How Treatable? - El Sayed Farag
What Have We Learned From the Mission Lifeline Registry? - Alice Jacobs
The REDUCER for Refractory Angina: COSIRA II - Gregg Stone
ACS Prediction by CT - Yukio Ozaki
The Power of New Biomarkers to Detect Early Ischemia - Thomas Luescher
Keeping Door-To-Balloon Time Under Control - James Blankenship
Translational Research for Patients Post-MI - What Works and What Does Not Work? - Timothy Henry
Intravenously Delivered Mesenchymal Stem Cells Improve Cardiac Function in AMI in Mice - Stephen Epstein
Use and Need of Embolic Protection During STEMI - Chaim Lotan
Loading Simple Education